Short talks Pharmacology 14
Ion channels, drug development

Programme

• 17:30 – 17:45 10 Min. 5 Min.

  • Oral presentation
  • 64

  Improving chemosensitivity in cancer - A novel role for Two Pore Channel 2

  • Karin Bartel (Munich / DE)

   Cancer pharmacology , Ion channels and membrane transporters
• 17:45 – 18:00 10 Min. 5 Min.

  • Oral presentation
  • 65

  TRPC5 controls the adrenaline-mediated counter regulation of hypoglycemia

  • Marc Freichel (Heidelberg / DE)

   CNS / endocrine pharmacology, Ion channels and membrane transporters
• 18:00 – 18:15 10 Min. 5 Min.

  • Oral presentation
  • 66

  Enhanced inactivation increases the sensitivity of pathogenic Cav1.3 L-type Ca²⁺-channel variants to dihydropyridine Ca²⁺ channel blockers

  • Ferenc Török (Innsbruck / AT)

   CNS / endocrine pharmacology, Ion channels and membrane transporters
• 18:15 – 18:30 10 Min. 5 Min.

  • Oral presentation
  • 67

  Regulation of Raf kinase inhibitor protein levels under ischemic condition

  • Constanze Schanbacher (Würzburg / DE)

   Cardiac pharmacology, Disease models, drug development